Liposomal diltiazem HCl as ocular drug delivery system for glaucoma

References

• Chiang CH. Ocular drug delivery systems of antiglaucoma agents. J Med Sci 1991;12:157–70
   Google Scholar
• Santafe J, Martinez de Ibarreta MJ, Segarra J, Melena J. A long lasting hypertensive effect of topical diltiazem on the intra-ocular pressure in conscious rabbits. Naunyn-Schmiedebergs Arch Pharm 1997;355:645–50
   PubMed Web of Science ®Google Scholar
• Mito T, Delamere NA, Coca-Prados M. Calcium dependent regulation of action transport in cultured human non pig-mented ciliary epithelial cells. Am J Physiol 1993;264:519–26
   Google Scholar
• Morrison JC, Freddo TF. Anatomy, microcirculation, and ultrastructure of the ciliary body. In: Ritch R, Shields MB, Krupin T, eds. The glaucomas. 2nd ed. St. Louis (MO): Year book Inc.; 1996:125–38
   Google Scholar
• Edelman JL, Sachs G, Adorante JS. Ion transport asymmetry and functional coupling in bovine pigmented and nonpig-mented ciliary epithelial cells. Am J Physiol 1994;266:1210–21
   Google Scholar
• Bangham AD, Standish MM, Watkins JC. Diffusion of univalent ions across the lamellae of swollen phospholipids. J Mol Biol 1965;13:238–52
   PubMed Web of Science ®Google Scholar
• Gregoriadis G. The carrier potential of liposomes in biology and medicine. New Engl J Med 1976;295:704–10
   PubMed Web of Science ®Google Scholar
• Fendler JH, Romero A. Liposomes as drug carriers. Life Sci 1977;20:1109–20
   PubMed Web of Science ®Google Scholar
• Achouri D, Alhanout K, Piccerelle P, Andrieu V. Recent advances in ocular drug delivery. Drug Dev Indus Pharm 2012;16:1–19
   Google Scholar
• Singh K, Mezei M. Liposomal ophthalmic drug delivery system II.Dihydrostreptomycin sulfate. Int J Pharm 1983;16:339–44
   Web of Science ®Google Scholar
• Meisner D, Pringle J, Mezei M. Liposomal ophthalmic drug delivery III. Pharmacodynamics and biodisposition studies of atropine. Int J Pharm 1989;55:105–13
   Web of Science ®Google Scholar
• Li VHK, Lee VHL, Robinson JR. Influence of drug properties and routes of administration on the design of sustained and controlled release system. In: Robinson JR, Lee VHL, eds. Controlled drug delivery. 2nd ed. New York: Marcel Dekker; 1987:3–61
   Google Scholar
• Abd El-Motaleb ME. Performance of propranolol hydrochloride in certain ophthalmic formulation [M.Sc. Pharm. thesis]. Egypt: Faculty of Pharmacy, Assiut University; 1991
   Google Scholar
• Payne NL, Browning I, Hynes CA. Characterization of proliposomes. J Pharmceut Sci 1986;75:330–3
   PubMed Web of Science ®Google Scholar
• Wang S, Ye T, Yang B, et al. 7-Ethyl-10-hydroxycamptothecin proliposomes with a novel preparation method: optimized formulation, characterization and in-vivo evaluation. Drug Dev Indus Pharm 2013;39:393–401
   PubMed Web of Science ®Google Scholar
• Mehanna MM, Elmaradny HA, Samaha MW. Mucoadhesive liposomes as ocular delivery system: physical, microbiological, and in vivo assessment. Drug Dev Indus Pharm 2010;36:108–18
   PubMed Web of Science ®Google Scholar
• Dhoot NO, Wheatley MA. Microencapsulated liposomes in controlled drug delivery: strategies to modulate drug release and eliminate the burst effect. J Pharm Sci 2003;92:679–89
   PubMed Web of Science ®Google Scholar
• Perrett S, Golding M, Williams WP. A simple method for the preparation of liposomes for pharmaceutical applications: characterization of liposomes. J Pharm Pharmacol 1991;43:154–61
   PubMed Web of Science ®Google Scholar
• Rengel RG, Barisic K, Pavelic Z, et al. High efficiency entrapment of superoxide dismutase into mucoadhesive chiston-coated liposome. Euro J Pharm Sci 2002;15:441–8
   PubMed Web of Science ®Google Scholar
• Hathout RM, Mansour S, Mortada ND, Guinedi AS. Liposomes as an ocular delivery system for acetazolamide: in vitro and in vivo studies. AAPS PharmSciTech 2007;8:1–13
   PubMed Web of Science ®Google Scholar
• Udupa N, Chandraprakash KS, Umadevi P, Pillai GK. Formulation and evaluation of methotrexate niosomes. Drug Dev Ind Pharm 1993;19:1331–42
   Web of Science ®Google Scholar
• Aggarwal D, Kaur IP. Improved pharmacodynamics of timolol maelate from a mucoadhesive niosomal ophthalmic drug delivery system. Int J Pharm 2005;290:155–9
   PubMed Web of Science ®Google Scholar
• El-Badry M. Performance of propranolol hydrochloride in certain ophthalmic formulations [M.Sc. thesis]. Egypt: Faculty of Pharmacy, Assiut University; 1991
   Google Scholar
• Gibaldi M. Biopharmaceutics and clinical pharmacokinetics. In: Delivery of drugs: dosage form and their evaluation. 4th ed. Philadelphia, London: Lea & Febiger; 1991:41–73
   Google Scholar
• Kaur IP, Singh M, Kanwar M. Formulation and evaluation of ophthalmic preparation of acetazolamide. Int J Pharm 2000;199:119–27
   PubMed Web of Science ®Google Scholar
• Mazzo DJ, Obetz CL, Shuster J. Diltiazem hydrochloride. In: Britain HG, ed. Analytical profiles of drug substances and excipients. Vol. 23. San Diego: Academic Press; 1994:54–98
   Google Scholar
• New RRC, ed. Liposomes: a practical approach. Oxford: IRL Press at Oxford University Press; 1990
   Google Scholar
• Bandyopadhyay P, Neeta NS. Evidence for vesicle formation 1:1 nonionic surfactant span 60 and fatty alcohol mixtures in aqueous ethanol: potential delivery vehicle composition. Colloids Surf B: Biointerfaces 2007;58:305–8
   PubMed Web of Science ®Google Scholar
• El-Nabarawi MA, Bendas ER, El Rehem RTA, Abary MYS. Formulation and evaluation of dispersed paroxetine liposomes in gel. J Chem Pharm Res 2012;4:2209–22
   Google Scholar
• Tiwari Sandip B, Udupa N, Rao BSS, Uma Devi P. Thermosensitive liposomes and localised hyperthermia – an effective bimodality approach for tumour management. Indian J Pharmacol 2000;32:214–20
   Google Scholar
• Rogerson A, Cummings J, Florence AT. A driamycin loaded niosomes: drug entrapment, stability and release. J Microcapsule 1987;4:321–8
   PubMed Web of Science ®Google Scholar
• Gregoriadis G. Liposome technology. 2nd ed., Vols 1–3. Boca Raton (FL): CRC Press; 1993
   Google Scholar
• Johnson, SM. The effect of charge and cholesterol on the size and thickness sonicated phospholipid vesicles. Biochim Biophys Acta 1973;307:27–41
   PubMed Web of Science ®Google Scholar
• McIntosh TJ. The effect of cholesterol on the structure of phosphatidylcholine bilayers. Biochem Biophys Acta 1978;513:43–58
   PubMed Web of Science ®Google Scholar
• Gabizon A, Papahadjopoulos D. Liposome formulations with prolonged circulation time in blood and enhanced uptake by tumors. Proc Natl Acad Sci USA 1988;85:6949–53
   PubMed Web of Science ®Google Scholar
• Jahnig F, Harlos K, Vogel H, Eible H. Electrostatic interactions at charged lipid membranes: electrostatically incuced tilt. Biochemistry 1979;18:1460–8
   Google Scholar
• Glava-Dodov M, Fredro-Kumbarad E, Calis S, et al. Formulation and characterisation of 5-fluorouracil loaded liposomes. Bull Chemists Technologists Macedonia 2004;23:13–18
   Google Scholar
• Katragadda A, Bridgman R, Betageri G. Effect of liposome composition and cholesterol on the cellular uptake of stavudine by human monocyte/macrophages. Cell Mol Biol Lett 2000;5:483–93
   Web of Science ®Google Scholar
• Duxbury MS, Whang EE. RNA interference: a practical approach. J Surg Res 2004;117:339–44
   PubMed Web of Science ®Google Scholar
• Cocera M, Lopez O, Coderch L, et al. Permeability investigation of phospholipids liposomes by adding cholesterol. Colloids Surf 2003;221:9–17
   Google Scholar
• Barber RF, Shek PN. Liposomes as a topical ocular drug delivery system. In: Rolland A, ed. Pharmaceutical particulate carrier. New York: Marcel Dekker; 1993:1–20
   Google Scholar
• Jousma H, Talsma H, Spies F, et al. Characterization of liposomes. The influence of extrusion of multilamellar vesicles through polycarbonate membranes on particle size, particles size distribution and number of bilayers. Int J Pharm 1987;35:263–74
   Web of Science ®Google Scholar
• Abdalla RR, Mahdy MA, Abd El-Rhman MM, Megrab NA. Ocular controlled delivery of brimonidine using liposomes as a particulate carrier. Zag J Pharm Sci 2001;2:30–5
   Google Scholar
• Paul S, Mondol R, Ranjit S, Mti S. Antiglaucomatic niosomal system: recent trend in ocular drug delivery research. Int J Pharm Pharm Sci 2010;2:975–1491
   Google Scholar